David Coughlan

This inventor holds 22 USPTO granted patents and 29 published patent applications, plus 2 CIPO patents and 6 EPO patents, primarily in Pharmaceutical Compositions. Top assignees: Ds Biopharma Limited, Dignity Sciences Limited, Afimmune Limited. Active years: 2012-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Coughlan. Retrieved from https://idiyas.com/inventor/david-coughlan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 22 (Patent Applications = 29)

% Patents Active = 63.6

CIPO Patents = 2 (Patent Applications = 5)

EPO Patents = 6 (Patent Applications = 22)

Average Co-Inventor Count = 2.9

ph-index = 6

Forward Citations = 61(Granted Patents)

Location History:

Leopardstown, IE (2014 - 2015)
Dublin, IE (2012 - 2024)

Company Filing History:

Dignity Sciences Limited

Dignity Sciences Limted

patent

Years Active: 2012-2025

Loading Chart...

Areas of Expertise:

15-HEPE

DGLA

Hematologic Disorders

Cancer Treatment

Fatty Acids

Pharmaceutical Compositions

Oxo-Derivatives

Cosmetic Compositions

Salts of Fatty Acids

Neurologic Diseases

EPA

GLA

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12274685 - Compositions comprising 15-HEPE and methods of using the same (2025-04-14),

2. 12076304 - Compositions comprising 15-HEPE and methods of treating or preventing hematologic disorders, and/or related diseases (2024-09-03),

3. 12017986 - Compositions comprising oxo-derivatives of fatty acids and methods of making and using same (2024-06-25),

4. 11478442 - Pharmaceutical compositions comprising DGLA and use of same (2022-10-25),

5. 10849870 - Pharmaceutical compositions comprising DGLA and use of same (2020-12-01),

6. 10716773 - Compositions comprising 15-HEPE and methods of treating or preventing cancer and neurologic disease (2020-07-21),

7. 10570083 - Compositions comprising oxo-derivatives of fatty acids and methods of making and using same (2020-02-25),

8. 10544088 - Pharmaceutically acceptable salts of fatty acids (2020-01-28),

9. 10537543 - Pharmaceutical compositions comprising DGLA and use of same (2020-01-21),

10. 10231945 - Compositions comprising 15-HEPE and methods of using the same (2019-03-19),

11. 10105333 - Pharmaceutical compositions comprising DGLA and use of same (2018-10-23),

12. 10047033 - Compositions comprising oxo-derivatives of fatty acids and methods of making and using same (2018-08-14),

13. 10017453 - Pharmaceutically acceptable salts of fatty acids (2018-07-10),

14. 9855238 - Compositions comprising 15-HEPE and methods of using the same (2018-01-02),

15. 9855236 - Pharmaceutical compositions comprising DGLA and/or 15-HETrE and methods of use thereof (2018-01-02),

Title: The Inventor David Coughlan from Dublin, IE

Introduction: David Coughlan is a renowned inventor based in Dublin, Ireland, known for his groundbreaking contributions to various industries through his innovative creations.

Latest Patents: David Coughlan holds several patents in the fields of technology, healthcare, and sustainable energy, showcasing his diverse range of expertise and interests.

Career Highlights: With a career spanning over two decades, David Coughlan has established himself as a leading figure in the world of innovation, with numerous successful inventions that have had a significant impact on society.

Collaborations: Throughout his career, David Coughlan has collaborated with top research institutions, universities, and companies worldwide, fostering a culture of innovation and knowledge-sharing within the industry.

Conclusion: David Coughlan's passion for pushing the boundaries of what is possible through his inventions continues to inspire the next generation of inventors and innovators globally.

Profile summary based on public USPTO records.